Department of Colorectal Surgery, North Middlesex Hospital NHS Trust, London, UK.
National Bowel Research Centre, Blizard Institute, QMUL, London, UK.
ANZ J Surg. 2021 Nov;91(11):2322-2329. doi: 10.1111/ans.16941. Epub 2021 May 20.
The majority of colorectal cancer is diagnosed in people aged >65 years, yet the elderly are less likely to undergo curative surgery. Chronological age is poorly correlated with post-operative outcomes and is not an acceptable measure of risk. Conversely, frailty is a strong predictor of poor post-operative outcomes and presents an opportunity for optimisation. This systematic review aims to assess the evidence between frailty and outcomes in patients of all ages undergoing colorectal cancer resections and to compare the predictive value of frailty status to that of age alone.
The review was registered on Prospero, CRD42019150542. PubMed was searched for articles reporting outcomes for frail patients undergoing elective or emergency colorectal cancer resection up until August 2019. All studies reporting outcomes in frail patients were deemed eligible for inclusion and assessed according to the PRISMA guidelines.
Of the 143 identified studies, 17 were eligible for inclusion. Study type, frailty assessments and outcomes measured were highly variable. 'Frailty' was associated with significantly higher rates of post-operative complications (7/7 studies), post-operative mortality (5/7 studies), readmission (3/4 studies) and length of stay (3/3 studies). Seven of 11 studies reported no association between age and adverse outcomes.
Frailty is a predictor of poor clinical outcomes in patients undergoing surgery for colorectal cancer. Standardisation of frailty assessment and outcome measure is needed. Accurate risk stratification of patients will allow us to make informed treatment decisions, identify patients who may benefit from preoperative intervention and tailor post-operative care.
大多数结直肠癌发生在年龄>65 岁的人群中,但老年人接受根治性手术的可能性较小。年龄与术后结果相关性差,不能作为风险的可靠指标。相反,虚弱是术后预后不良的强有力预测因素,为优化治疗提供了机会。本系统评价旨在评估所有年龄段接受结直肠癌切除术的患者虚弱与结局之间的证据,并比较虚弱状态与单独年龄的预测价值。
本综述已在 Prospéro 上注册,CRD42019150542。检索了截至 2019 年 8 月报道虚弱患者接受择期或紧急结直肠癌切除术结果的文章。所有报道虚弱患者结局的研究均被认为符合纳入标准,并根据 PRISMA 指南进行评估。
在 143 项确定的研究中,有 17 项符合纳入标准。研究类型、虚弱评估和测量的结局差异很大。“虚弱”与更高的术后并发症发生率(7/7 项研究)、术后死亡率(5/7 项研究)、再入院率(3/4 项研究)和住院时间(3/3 项研究)显著相关。11 项研究中有 7 项报告年龄与不良结局之间无关联。
虚弱是接受结直肠癌手术患者临床结局不良的预测因素。需要对虚弱评估和结局测量进行标准化。对患者进行准确的风险分层可以帮助我们做出明智的治疗决策,确定可能受益于术前干预的患者,并调整术后护理。